2022 Preceptorship: How we do PSMA (Prostate Specific Membrane Antigen) Theranostics
In line with one of our program’s key pillars of Education and Leadership, we are pleased to share an online educational program produced from the two-day 2022 ProsTIC Preceptorship.
Together with multidisciplinary colleagues and world leading experts we provided the world with the latest in research, case studies, practical applications, and the future of PSMA Imaging and Theranostics.
Our cancer imaging team performed our first PSMA PET/CT in 2014, and our first Lutetium PSMA therapy in 2015.
Our first preceptorship proudly shared with you how we conduct our successful PSMA program.
Related links
2024 Preceptorship: PSMA Theranostics: Precision Oncology in Practice
We are thrilled to announce our 2024 ProsTIC Preceptorship: Precision Oncology in Practice.
This immersive, multidisciplinary course is tailored for professionals across nuclear medicine, medical oncology, radiation oncology, and urology who are seeking to advance their skills and knowledge of theranostics. With both national and international faculty and guests, we are sure to engage in sessions that challenge and excite.
Over 420 delegates participated in person and online in our previous 2022 preceptorship as we showcased how our multidisciplinary team at Peter Mac, and our valued collaborators, established and run a successful PSMA Theranostics program. Our 2024 preceptorship builds on knowledge in this rapidly evolving field.
The earlybird deadline is the 21st of January 2024 so make sure you register here before this date to take advantage of the discounted rates.
We can't wait to see you in-person to help shape the future of theranostics and support improved patient outcomes globally.